| Product Code: ETC088664 | Publication Date: Jun 2021 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The Thailand Radiopharmaceutical Market was estimated at USD 248 Million in 2025 and is projected to reach USD 284 Million by 2032, growing at a CAGR of 2.0% from 2026 to 2032. This growth trajectory is primarily fueled by the rapid advancements in diagnostic imaging technologies, significantly improving the accuracy of disease detection and treatment monitoring. Additionally, the increasing prevalence of chronic diseases is heightening the demand for radiopharmaceutical applications, particularly in oncology and cardiology.
The Thailand radiopharmaceutical market has shown a promising recovery following its decline of 3.7% in 2021, heavily influenced by the pandemic's disruption. A 2.5% growth in 2022 marked the beginning of a more stable phase, bolstered by increasing investments in healthcare infrastructure and advancements in technology. The market continued to gain momentum with 3.1% growth in 2023, supported by rising consumer demand for precision medicine and innovative diagnostic tools. Projections indicate that this trend will persist, with modest growth rates around 2.8% to 3.3% anticipated through 2032. Continued focus on policy improvements and digitalization in healthcare are likely to drive further expansion and enhance the accessibility of radiopharmaceuticals.
This graph highlights how the Thailand Radiopharmaceutical Market has steadily grown over the past five years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -3.7% | Weak domestic healthcare spending dampened radiopharmaceutical production demand |
| 2022 | 2.5% | Higher investment in nuclear medicine facilities boosts radiopharmaceutical production |
| 2023 | 3.1% | Technology integration in radiopharmaceuticals boosts production efficiency and quality |
| 2024 | 2.8% | Export driven investments in production facilities boost radiopharmaceutical capacity utilization |
| 2025 | 3.1% | Regional investment in advanced manufacturing technology boosts radiopharmaceutical production |
| 2026 | 2.8% | New radiopharmaceutical production facility boosts local manufacturing capabilities |
| 2027 | 2.3% | New manufacturing facilities boost Thailand's radiopharmaceutical output capacity |
| 2028 | 2.7% | Radiopharmaceutical exports boosted advanced manufacturing equipment investments |
| 2029 | 3.1% | Local radiopharmaceutical production facilities boost supply chain reliability |
| 2030 | 2.8% | Radiopharmaceutical supply chain optimization boosted local manufacturing capacity |
| 2031 | 2.9% | Improved radiopharmaceutical production efficiency boosts export market competitiveness |
| 2032 | 3.3% | Domestic healthcare investment boosted radiopharmaceutical manufacturing capabilities and distribution |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
At the forefront of the Thailand Radiopharmaceutical Market is the integration of advanced medical imaging technologies. These innovations enhance the precision of nuclear medicine practices, enabling healthcare providers to deliver superior patient outcomes. As healthcare infrastructure continues to strengthen, accessibility to these sophisticated treatments is rapidly improving, thereby increasing market potential.
Furthermore, government support plays a pivotal role in propelling the market forward. Initiatives aimed at improving healthcare accessibility and encouraging research in nuclear medicine are fostering an environment conducive to growth. As a result, the radiopharmaceutical sector is becoming integral to Thailand's healthcare landscape.
Despite the favorable growth prospects, the Thailand Radiopharmaceutical Market faces several restraints. Regulatory compliance is paramount due to the inherent nature of radiopharmaceuticals, which are subject to stringent safety and handling protocols. The logistics involved in the transportation and disposal of radioactive materials present additional hurdles that companies must navigate. Moreover, the complexity of maintaining these regulations can lead to increased operational costs, potentially impacting the market's overall growth.
Several trends are currently shaping the Thailand Radiopharmaceutical Market. There is a notable shift towards personalized medicine, particularly in oncology, where radiopharmaceuticals are being developed to target specific cancer types more effectively. Moreover, the rise of artificial intelligence and machine learning in diagnostic imaging is optimizing treatment planning and patient management. Another emerging trend is the integration of hybrid imaging modalities, which enhance the diagnostic capabilities of radiopharmaceuticals.
Investment opportunities abound within the Thailand Radiopharmaceutical Market, particularly in research and development. The growing emphasis on personalized medicine offers pathways for innovation in radiopharmaceutical formulations. Additionally, collaborations between government entities and private firms can lead to advancements in imaging technologies and therapeutic applications. Expansion of facilities dedicated to nuclear medicine and radiopharmacy will further capitalize on the increasing demand for diagnostic services.
The Thai government has implemented various policies aimed at bolstering the healthcare sector, which includes the radiopharmaceutical domain. Public spending on healthcare infrastructure has increased significantly, focusing on enhancing diagnostic services. Incentives for research in nuclear medicine are also being promoted, encouraging local companies to innovate and develop new radiopharmaceutical products. These initiatives are designed to improve access to advanced medical care for the Thai populace, further stimulating market growth.
Looking ahead to 2026-2032, the Thailand Radiopharmaceutical Market is poised for sustained growth. The ongoing advancements in diagnostic imaging and an increasing focus on non-invasive techniques will likely expand the applications of radiopharmaceuticals. As the healthcare landscape evolves, the integration of cutting-edge technologies and collaborative efforts between stakeholders will be critical in enhancing treatment capabilities and improving patient outcomes. This trajectory indicates a robust future for radiopharmaceuticals in Thailand.
Recent developments in the Thailand Radiopharmaceutical Market have focused on enhancing the production capabilities of radiopharmaceuticals. Facilities are being upgraded to meet international standards, ensuring safety and efficacy in the manufacturing process. Additionally, there has been an uptick in partnerships between academic institutions and healthcare providers to foster innovation in nuclear medicine applications. These collaborative efforts are expected to yield significant advancements in diagnostic imaging and therapeutic methodologies.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Radiopharmaceutical Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Radiopharmaceutical Market Revenues & Volume, 2022 & 2032F |
3.3 Thailand Radiopharmaceutical Market - Industry Life Cycle |
3.4 Thailand Radiopharmaceutical Market - Porter's Five Forces |
3.5 Thailand Radiopharmaceutical Market Revenues & Volume Share, By Types, 2022 & 2032F |
3.6 Thailand Radiopharmaceutical Market Revenues & Volume Share, By Applications, 2022 & 2032F |
3.7 Thailand Radiopharmaceutical Market Revenues & Volume Share, By Procedural Volume Assessment, 2022 & 2032F |
3.8 Thailand Radiopharmaceutical Market Revenues & Volume Share, By Source, 2022 & 2032F |
3.9 Thailand Radiopharmaceutical Market Revenues & Volume Share, By End-users, 2022 & 2032F |
4 Thailand Radiopharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increase in prevalence of cancer and cardiovascular diseases in Thailand |
4.2.2 Growing awareness about the benefits of nuclear medicine and radiopharmaceuticals |
4.2.3 Technological advancements in radiopharmaceutical production and imaging techniques |
4.3 Market Restraints |
4.3.1 High costs associated with radiopharmaceutical production and procurement |
4.3.2 Lack of skilled professionals in the field of nuclear medicine |
4.3.3 Stringent regulatory requirements for radiopharmaceutical manufacturing and distribution |
5 Thailand Radiopharmaceutical Market Trends |
6 Thailand Radiopharmaceutical Market, By Types |
6.1 Thailand Radiopharmaceutical Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Thailand Radiopharmaceutical Market Revenues & Volume, By Types, 2022-2032F |
6.1.3 Thailand Radiopharmaceutical Market Revenues & Volume, By Diagnostic Nuclear Medicine, 2022-2032F |
6.1.4 Thailand Radiopharmaceutical Market Revenues & Volume, By Therapeutic Nuclear Medicine, 2022-2032F |
6.2 Thailand Radiopharmaceutical Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 Thailand Radiopharmaceutical Market Revenues & Volume, By Diagnostic Applications, 2022-2032F |
6.2.3 Thailand Radiopharmaceutical Market Revenues & Volume, By Therapeutic Applications, 2022-2032F |
6.3 Thailand Radiopharmaceutical Market, By Procedural Volume Assessment |
6.3.1 Overview and Analysis |
6.3.2 Thailand Radiopharmaceutical Market Revenues & Volume, By Diagnostic Procedures, 2022-2032F |
6.3.3 Thailand Radiopharmaceutical Market Revenues & Volume, By Therapeutic Procedures, 2022-2032F |
6.4 Thailand Radiopharmaceutical Market, By Source |
6.4.1 Overview and Analysis |
6.4.2 Thailand Radiopharmaceutical Market Revenues & Volume, By Nuclear Reactors, 2022-2032F |
6.4.3 Thailand Radiopharmaceutical Market Revenues & Volume, By Cyclotrons, 2022-2032F |
6.5 Thailand Radiopharmaceutical Market, By End-users |
6.5.1 Overview and Analysis |
6.5.2 Thailand Radiopharmaceutical Market Revenues & Volume, By Hospitals, 2022-2032F |
6.5.3 Thailand Radiopharmaceutical Market Revenues & Volume, By Ambulatory Surgical Centers, 2022-2032F |
6.5.4 Thailand Radiopharmaceutical Market Revenues & Volume, By Diagnostic Centers, 2022-2032F |
6.5.5 Thailand Radiopharmaceutical Market Revenues & Volume, By Cancer Research Institutes, 2022-2032F |
6.5.6 Thailand Radiopharmaceutical Market Revenues & Volume, By Others, 2022-2032F |
7 Thailand Radiopharmaceutical Market Import-Export Trade Statistics |
7.1 Thailand Radiopharmaceutical Market Export to Major Countries |
7.2 Thailand Radiopharmaceutical Market Imports from Major Countries |
8 Thailand Radiopharmaceutical Market Key Performance Indicators |
8.1 Number of new radiopharmaceutical products introduced in the market |
8.2 Investment in research and development of new radiopharmaceuticals |
8.3 Adoption rate of nuclear medicine and radiopharmaceutical imaging techniques in healthcare facilities |
9 Thailand Radiopharmaceutical Market - Opportunity Assessment |
9.1 Thailand Radiopharmaceutical Market Opportunity Assessment, By Types, 2022 & 2032F |
9.2 Thailand Radiopharmaceutical Market Opportunity Assessment, By Applications, 2022 & 2032F |
9.3 Thailand Radiopharmaceutical Market Opportunity Assessment, By Procedural Volume Assessment, 2022 & 2032F |
9.4 Thailand Radiopharmaceutical Market Opportunity Assessment, By Source, 2022 & 2032F |
9.5 Thailand Radiopharmaceutical Market Opportunity Assessment, By End-users, 2022 & 2032F |
10 Thailand Radiopharmaceutical Market - Competitive Landscape |
10.1 Thailand Radiopharmaceutical Market Revenue Share, By Companies, 2025 |
10.2 Thailand Radiopharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here